{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:26:43Z","timestamp":1792762003281,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.intimp.2022.109198","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T21:46:07Z","timestamp":1663191967000},"page":"109198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria"],"prefix":"10.1016","volume":"112","author":[{"given":"Sinem","family":"Ayse Ornek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Orcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emek","family":"Kocaturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.intimp.2022.109198_b0005","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"Endorsed by the following societies: AaaaiWao, The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.intimp.2022.109198_b0010","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109198_b0015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/bjd.14768","article-title":"Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis","volume":"175","author":"Guillen-Aguinaga","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2022.109198_b0020","doi-asserted-by":"crossref","unstructured":"M. Sharma, C. Bennett, B. Carter, S.N. Cohen, H1-antihistamines for chronic spontaneous urticaria: An abridged cochrane systematic review, J. Am. Acad. Dermatol. 73 (4) (2015) 710-716 e4.","DOI":"10.1016\/j.jaad.2015.06.048"},{"key":"10.1016\/j.intimp.2022.109198_b0025","doi-asserted-by":"crossref","unstructured":"P. Phinyo, P. Koompawichit, S. Nochaiwong, N. Tovanabutra, S. Chiewchanvit, M. Chuamanochan, Comparative efficacy and acceptability of licensed dose second-generation antihistamines in chronic spontaneous urticaria: a network meta-analysis, J. Allergy Clin. Immunol. Pract. 9 (2) (2021) 956-970 e57.","DOI":"10.1016\/j.jaip.2020.08.055"},{"issue":"1","key":"10.1016\/j.intimp.2022.109198_b0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/bjd.12846","article-title":"Night-time sedating h1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial","volume":"171","author":"Staevska","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109198_b0035","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","article-title":"Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Nettis","year":"2004","journal-title":"Clin. Exp. Allergy"},{"issue":"4","key":"10.1016\/j.intimp.2022.109198_b0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.18176\/jiaci.0649","article-title":"Efficacy and safety of up-dosing antihistamines in chronic spontaneous urticaria: a systematic review of the literature","volume":"31","author":"Iriarte Sotes","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109198_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2133.1987.tb04095.x","article-title":"Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study","volume":"117","author":"Bleehen","year":"1987","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109198_b0050","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/all.13209","article-title":"The burden of chronic spontaneous urticaria is substantial: real-world evidence from assure-csu","volume":"72","author":"Maurer","year":"2017","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.intimp.2022.109198_b0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2133.2005.06976.x","article-title":"Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity","volume":"154","author":"Staubach","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109198_b0060","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/all.12901","article-title":"Definition, aims, and implementation of ga(2) len urticaria centers of reference and excellence","volume":"71","author":"Maurer","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2022.109198_b0065","doi-asserted-by":"crossref","unstructured":"K. Weller, A. Groffik, M.K. Church, T. Hawro, K. Krause, M. Metz, P. Martus, T.B. Casale, P. Staubach, M. Maurer, Development and validation of the urticaria control test: A patient-reported outcome instrument for assessing urticaria control, J. Allergy Clin. Immunol. 133 (5) (2014) 1365-72, 1372 e1-6.","DOI":"10.1016\/j.jaci.2013.12.1076"},{"issue":"1","key":"10.1016\/j.intimp.2022.109198_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2018.11.007","article-title":"Validation of the turkish version of the urticaria control test: correlation with other tools and comparison between spontaneous and inducible chronic urticaria","volume":"12","author":"Kocaturk","year":"2019","journal-title":"World Allergy Organ. J."},{"issue":"3","key":"10.1016\/j.intimp.2022.109198_b0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.intimp.2022.109198_b0080","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1684\/ejd.2014.2323","article-title":"Adherence to best practice guidelines in chronic spontaneous urticaria (csu) improves patient outcome","volume":"24","author":"Conlon","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.intimp.2022.109198_b0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.23822\/EurAnnACI.1764-1489.103","article-title":"Clinical experience of a chronic urticaria referral university center","volume":"52","author":"Andrade Coelho Dias","year":"2020","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109198_b0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/cea.12494","article-title":"BSACI guideline for the management of chronic urticaria and angioedema","volume":"45","author":"Powell","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.intimp.2022.109198_b0095","first-page":"82","article-title":"The turkish guideline for the diagnosis and management of urticaria-2016","volume":"50","author":"Kocaturk Goncu","year":"2016","journal-title":"Turkderm \u2013 Arch. Turk. Dermatol. Venerol."},{"key":"10.1016\/j.intimp.2022.109198_b0100","article-title":"Up-dosing antihistamines in chronic spontaneous urticaria: efficacy and safety. A systematic review of the literature","author":"Iriarte Sotes","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109198_b0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","article-title":"The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria","volume":"125","author":"Staevska","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109198_b0110","doi-asserted-by":"crossref","unstructured":"L. Zhang, J. Wu, Y. Qi, H. Zhu, X. Yao, M. Li, J. Li, Z. Guo, X. Su, W. Lai, S. Hao, Y. Li, Y. Li, C. Yao, F. Li, H. Wang, Q. Liu, H. Long, Q. Lu, X. Gao, H. Chen, T. Xiao, Long-term combinations and updosing of second-generation h1-antihistamines show efficacy and safety in the treatment of chronic spontaneous urticaria: A multicenter real-life pilot study, J. Allergy Clin. Immunol. Pract. 8(5) (2020) 1733-1736 e11.","DOI":"10.1016\/j.jaip.2019.12.006"},{"issue":"3","key":"10.1016\/j.intimp.2022.109198_b0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2004.06.018","article-title":"Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria","volume":"114","author":"Di Lorenzo","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109198_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/all.14757","article-title":"Predictors of treatment response in chronic spontaneous urticaria","author":"Fok","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2022.109198_b0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jdermsci.2017.02.283","article-title":"Management of chronic inducible urticaria according to the guidelines: a prospective controlled study","volume":"87","author":"Kocaturk","year":"2017","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109198_b0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2013.08.011","article-title":"Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis","volume":"73","author":"Metz","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2022.109198_b0135","doi-asserted-by":"crossref","first-page":"eAO5175","DOI":"10.31744\/einstein_journal\/2020AO5175","article-title":"Chronic inducible urticaria: confirmation through challenge tests and response to treatment","volume":"18","author":"Pereira","year":"2020","journal-title":"Einstein (Sao Paulo)"},{"issue":"6","key":"10.1016\/j.intimp.2022.109198_b0140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2500\/aap.2011.32.3483","article-title":"Clinical and laboratory features of antihistamine-resistant chronic idiopathic urticaria","volume":"32","author":"Magen","year":"2011","journal-title":"Allergy Asthma Proc"},{"issue":"7","key":"10.1016\/j.intimp.2022.109198_b0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2340\/00015555-2941","article-title":"Clinical features of chronic spontaneous urticaria that predict disease prognosis and refractoriness to standard treatment","volume":"98","author":"Curto-Barredo","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.intimp.2022.109198_b0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13601-019-0275-6","article-title":"Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: An observational study","volume":"9","author":"Ulambayar","year":"2019","journal-title":"Clin Transl Allergy"},{"issue":"2","key":"10.1016\/j.intimp.2022.109198_b0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000452626","article-title":"Altered systemic adipokines in patients with chronic urticaria","volume":"171","author":"Trinh","year":"2016","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109198_b0160","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/cea.12900","article-title":"H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life aware study","volume":"47","author":"Maurer","year":"2017","journal-title":"Clin. Exp. Allergy"},{"issue":"8","key":"10.1016\/j.intimp.2022.109198_b0165","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/all.13430","article-title":"Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from assure-csu","volume":"73","author":"Sussman","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2022.109198_b0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13223-020-00496-0","article-title":"Refractory chronic urticaria in adults: clinical characterization and predictors of severity","volume":"16","author":"Alen Coutinho","year":"2020","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109198_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000507218","article-title":"Urticaria: Collegium internationale allergologicum (cia) update 2020","volume":"181","author":"Maurer","year":"2020","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109198_b0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2500\/aap.2019.40.4230","article-title":"Factors related to omalizumab resistance in chronic spontaneous urticaria","volume":"40","author":"Magen","year":"2019","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.intimp.2022.109198_b0185","article-title":"The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: real-life data","volume":"32","author":"Salman","year":"2019","journal-title":"Dermatol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2022.109198_b0190","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/all.13352","article-title":"C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria","volume":"73","author":"Kolkhir","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2022.109198_b0195","doi-asserted-by":"crossref","unstructured":"T. Ohanyan, N. Schoepke, B. Bolukbasi, M. Metz, T. Hawro, T. Zuberbier, A. Peveling-Oberhag, P. Staubach, M. MaurerK. Weller, Responsiveness and minimal important difference of the urticaria control test, J. Allergy Clin. Immunol. 140(6) (2017) 1710-1713 e11.","DOI":"10.1016\/j.jaci.2017.04.050"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:49:35Z","timestamp":1761587375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922006828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":39,"alternative-id":["S1567576922006828"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109198","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109198"}}